Immune checkpoint inhibitors in prostate cancer: Current and future practice

touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts consider the current role of immune checkpoint inhibitors in prostate cancer and possible future directions. The experts Prof. Karim Fizazi - Gustave Roussy, Villejuif, France Dr Sandy Srinivas - Stanford University, Stanford, CA, USA Prof. Johann de Bono - The Institute of Cancer Research, London, UK This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Merck Sharp & Dohme Corp. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/icis-prostate-cancer/